OncoImmunology
Volume 2, 2013 - Issue 8
Open access
990
Views
16
CrossRef citations to date
0
Altmetric
Author's View
HDAC inhibitors and their potential applications to glioblastoma therapy
Eleni Adamopoulou Laboratory of Immunology; Department of Vascular Neurology; Hertie Institute for Clinical Brain Research; University of Tuebingen; Tuebingen, Germany
& Ulrike Naumann Laboratory of Molecular Neuro-Oncology; Department of Vascular Neurology; Hertie Institute for Clinical Brain Research; University of Tuebingen; Tuebingen, GermanyCorrespondence[email protected]
Article: e25219
|
Received 27 May 2013, Accepted 29 May 2013, Published online: 10 Jun 2013
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.